What is the timeline?
Supply Chain Dive reported that the plan starts Aug. 1, with qualifying generic drugs staying at 0% for two years. The tariff would then rise to 100% for one year and 200% after that.
| Timeline | Planning impact |
|---|---|
| First two years | Temporary window to review sourcing |
| Year three | 100% duty would change landed-cost math |
| Later years | 200% duty would force major supply decisions |
| Policy uncertainty | Importers should plan scenarios, not one forecast |
Why this matters beyond pharma
Pharmaceutical supply chains rely on active ingredients, packaging, cold-chain handling, regulatory documentation, and long qualification cycles. Even a future tariff threat can affect supplier negotiations and inventory policy today.
What to do
- Map generic-drug exposure by country, supplier, and product family.
- Identify which products require long requalification timelines.
- Model inventory and sourcing scenarios before the duty-free window narrows.
- Keep compliance, procurement, and logistics teams aligned on tariff timing.